Kinedic Ltd
Back to BlogHealthcare Policy

Why Africa Should Stop Exporting Patients and Start Exporting Healthcare Excellence

Africa exports over a billion dollars a year in patients and imports little of the excellence they fly to find. The pattern is not destiny. Every country that reversed it did the same thing: it stopped chasing buildings and started building centres of excellence, research, and people.

Dr. Paul Akinyemi10 July 202611 min read
Request a consultation
Why Africa Should Stop Exporting Patients and Start Exporting Healthcare Excellence
~17 min listen
Share

A paediatric cardiologist from Enugu spent four years at a children's hospital in London learning to close congenital heart defects in infants who weigh less than a bag of sugar, working in a unit that performs several hundred of those operations a year and has performed them for four decades. She was, by the end of her fellowship, one of the more capable people in her sub-speciality anywhere — trusted with the smallest and sickest cases on the list, invited onto the papers, offered a consultant post at the unit that trained her. She took it. She operates on Nigerian children too, but they come to her, flown out at ruinous cost by families who have sold land or emptied a pension, and she sees perhaps a dozen of them a year among the several dozen British children on her list. The arithmetic of her career is that Nigeria trained her through medical school, the United Kingdom trained her to the frontier of her field, and Nigeria now buys her expertise back one child at a time — at the price of an international flight, a foreign hospital bill, and the near-certainty that the child who could not be flown out did not have the operation at all. She would come home. There is no unit at home performing enough of those operations for her to keep her hand in — and so there is no home for her to come to.

This is the pattern, in one physician. The continent trains the talent, exports it, and then rents it back at the highest possible price, in the least efficient possible form, for the smallest possible number of its own people.

The scale of what is being exported

Two things leave the continent, and they leave together. The first is patients. By every responsible estimate, Nigeria alone spends north of a billion US dollars a year on medical travel — citizens boarding planes to India, to the Gulf, to Britain, for care ranging from oncology and cardiac surgery to procedures that are, in the narrow clinical sense, entirely available at home. Across the continent the figure is a multiple of that. This is not a rounding error in a health budget. It is a river of private capital flowing out of African economies and into the hospital systems of other countries — capital that, pointed differently, is roughly the order of magnitude required to build the very centres the patients are flying to reach.

The second export is the people who would build those centres. The cardiologist in London is not an anecdote; she is a category. The doctors, nurses, radiographers, and biomedical engineers a country needs to run a cardiac programme are precisely the people the recruiting countries extract most efficiently, because they are trained to an internationally recognised standard and can be dropped into a foreign rota with minimal friction. So the continent pays twice. It pays to train the specialist, then it pays again — in foreign currency, at foreign prices — to be treated by that specialist abroad, or by his replacement, having lost him.

What the continent imports in return is strikingly little: some equipment, some pharmaceuticals, the occasional visiting surgical mission. It does not, for the most part, import the thing the patients are actually flying to find, which is not a scanner or a drug but a system that reliably produces good outcomes in a defined set of conditions. That system is buildable. The uncomfortable truth of the last thirty years is that it has largely not been built, and that this was a choice — a thousand small choices — rather than a fate.

This is not destiny, and other countries have proved it

The most useful thing to say about the outflow is that it is reversible, because it has been reversed. The countries that African patients now fly to were, within living memory, patient-exporters themselves.

India in the 1980s sent its wealthy abroad for cardiac surgery and its brightest doctors to Britain and America. It is now one of the largest destinations for medical travel on earth, and a net importer of foreign patients including a growing number of Africans. Turkey, thirty years ago a country whose elite treated Europe as its hospital, now runs hospital groups that market across the Middle East and Africa and treat hundreds of thousands of foreign patients a year. Thailand built a private-hospital sector around a small number of internationally accredited institutions that draw patients from across Asia and the Gulf. Singapore, starting from almost nothing at independence, made clinical excellence an explicit instrument of national policy and became the reference standard for the region.

These are not miracles, and it would be dishonest to pretend the transition was clean, cheap, or equitable — in each case it left the domestic poor some distance behind the foreigners who could pay. But they share a shape. None of them reversed the outflow by building more of the same thin, generalist hospital capacity spread evenly across the map. Each reversed it by pulling the same specific set of levers, and it is worth naming those levers plainly, because the African conversation tends to collapse them into a vague appeal to "investment" or "standards" that is too imprecise to act on.

Medical education — train them, and then keep them

The first lever is medical education, and the important word in it is not train but retain. Africa is not, in the main, failing to train good doctors. Nigerian, Kenyan, Ghanaian, and South African graduates pass the licensing examinations of the countries that recruit them at rates that settle the question of whether the training is adequate. The failure is downstream of the degree. It is the failure to hold the specialist inside the system long enough for his expertise to compound into an institution.

Training a cardiac surgeon to the frontier of the field takes fifteen years and the accumulated experience of a high-volume unit. If, at year fifteen, the surgeon leaves — because the theatre time is not there, because the salary gradient runs an order of magnitude the other way, because there is no team around him to make the work possible — then the country has funded fifteen years of formation and captured none of the return. Retention is not a soft human-resources concern to be addressed after the buildings go up. It is the central engine of the whole enterprise, because a centre of excellence is not a building; it is a team that has stayed together and done a difficult thing many times. The countries that reversed the outflow did so by making it possible, then attractive, for their best-trained people to build careers at home. Nothing else on this list works if this one does not.

Centres of excellence — volume, not spread

The second lever is centres of excellence, and the principle underneath it is the one the African health conversation resists most, because it sounds like inequity: outcomes come from volume, and volume comes from concentration. The unit that performs four hundred infant heart operations a year has better outcomes than four units performing a hundred each, and enormously better outcomes than forty units performing ten each. This is one of the most consistent findings in health-services research. Surgical mortality, complication rates, the ability to rescue a patient when something goes wrong — all of it improves with the number of times the team has done the procedure, and all of it degrades when the same caseload is smeared thinly across many sites.

The instinct in a large, under-served country is to spread capacity evenly — a cardiac unit in every state, an oncology centre in every region. It is a democratic instinct and it produces, reliably, a large number of mediocre units and not one excellent one. The alternative is politically harder and clinically far superior: concentrate the complex work in a few centres that do enough of it to be genuinely world-standard, and build the referral and transport systems that carry patients to them. A country does not need forty passable cardiac units. It needs two or three excellent ones — and those, not the forty, are what stop the planes to Chennai and Mumbai.

Research — the difference between using knowledge and making it

The third lever is research, and its role is more central than it looks. Research is often treated as a luxury layer, the thing a health system does once it has solved everything else. It is closer to the opposite. The institutions that draw foreign patients are, almost without exception, institutions that generate knowledge rather than only consuming it — that run trials, publish outcomes, and hold themselves to the standard of measured, reported results. The credibility that makes a patient trust a hospital with his life is built on exactly this: the sense that the institution knows precisely how well it does what it does, and improves it deliberately, rather than asserting quality in a brochure.

There is also a specifically African case for research. The disease burden here is not identical to the one the frontier institutions abroad were built to treat — the genetics, the co-morbidities, the drug responses in an African population are not always the ones the trials in Boston or London studied. A continent that only imports clinical knowledge is always treating its own people with second-hand assumptions. A continent that generates knowledge treats them with knowledge that fits — and, not incidentally, builds the credibility that turns a hospital into a destination.

Innovation — adapting to the constraint, sometimes leapfrogging it

The fourth lever is innovation, by which I do not mean the importing of expensive technology but the adaptation of technology to the actual constraints of the place. Africa has done this before, decisively, in domains other than health — the continent leapfrogged the fixed-line telephone entirely and built mobile-money systems more advanced than anything in the countries that had banked for a century. The same move is available in medicine. Unreliable power shapes what equipment can be run; distance and poor roads shape how follow-up can happen; a thin specialist workforce shapes how expertise can be extended.

Each of these constraints is also a design brief. Tele-consultation that lets one specialist cover a region, diagnostic tools built to run on intermittent power, task-shifting protocols that let a well-trained nurse safely carry work that would elsewhere require a doctor — these are not compromises grudgingly accepted. Done well, they are the innovations that let an African centre of excellence reach further per specialist than its equivalent abroad. The countries that reversed the outflow did not simply copy the Western hospital. They adapted it, and in places improved on it, because they had to.

Investment — patient capital that treats health as infrastructure

The fifth lever is investment, and the operative distinction is between charity and capital. Health in Africa has been financed, disproportionately, as charity — donor programmes, vertical disease funds, the mission hospital. Charity has done enormous good and it does not build centres of excellence, because charity funds treatment and centres of excellence require patient, long-horizon capital of the kind that treats a hospital the way a country treats a port or a power station: as infrastructure that repays over decades. The billion-plus dollars leaving Nigeria every year is proof that the capital exists and that citizens will spend it on health. The problem is not the absence of money. It is that the money is spent abroad, one plane ticket at a time, on foreign infrastructure, rather than pooled at home into institutions that would keep it circulating and compounding into capability.

The uncomfortable point about who has to choose home first

There is a harder thing underneath all five levers, and it is the reason they have not been pulled. As long as the elite fly out, there is no domestic constituency demanding that the excellence be built at home. The senator, the bank chairman, the oil executive, the professor — the people with the money, the voice, and the political weight to force a health system to improve — do not experience the domestic system as patients, because at the first serious diagnosis they are on a plane. Their exit removes them from the pool of people who would otherwise be furious, and effective, about the state of care at home. A system improves under pressure from the people it fails. When the people it would most fail simply leave, the pressure never lands, and the mediocrity is stable.

This is the quiet mechanism that keeps the pattern locked in place. It is not corruption and it is not incapacity, though both exist. It is that the constituency for excellence has opted out of the market that would produce it. Building world-standard care at home therefore requires something no policy document can mandate: it requires the people who have the option to leave to choose, at least sometimes, to stay — to place their own care, and their family's care, inside the domestic system, and in doing so to become the constituency that demands it be good. The excellence follows the demand. The demand follows the choice. And the choice has to be made by exactly the people who can most easily avoid making it.

What Kinedic is building

Our practice operates from Mabushi in Abuja, with clinical anchoring at Brookfield Clinics, six hundred metres away, for imaging, inpatient capacity, and acute escalation. We do not claim to be a national cardiac programme or a solution to a continental problem. We are a smaller instance of the same principle: that excellence can be assembled at home, on purpose, and that the way to begin reversing the outflow is to give the people who would otherwise fly out a reason to stay.

The consultants a member sees at and around this practice are, in the cases that matter, the same calibre of physician — and frequently the very same people — the member would have met in London or Baltimore, trained at Hammersmith or Johns Hopkins or the Royal Marsden and returned. The named-physician model, the coordinated care across every specialist and hospital encounter, the continuity held in the system rather than in one doctor's memory — these are the conditions under which a returned expert can practise at the level she was trained to, and under which a family can receive at home the care they would otherwise have boarded a plane to find. It is a small proof that the levers are real and can be pulled. Every family that chooses home is one more unit of the demand that, at scale, builds the centres the continent keeps flying past.

If you are weighing the model — for yourself, a parent, or your organisation — start a conversation with us. The first conversation is private and costs nothing.

If this piece raised a question worth a private answer, the first conversation is held in confidence, at no cost.